共 15 条
[1]
FOLTZ EL, 1956, FED PROC, V15, P422
[2]
FRISK AR, 1943, ACTA MED SCAND S JAN
[3]
HENDERSON W. H., 1958, ANTIBIOT MED AND CLIN THER, V5, P470
[4]
LAPP C, 1956, Prod Pharm, V11, P87
[5]
LAPP C, 1954, Prod Pharm, V9, P566
[6]
MARTELL JA, 1957, Patent No. 2798443
[7]
A NOTE ON MATHEMATICS OF ORAL SUSTAINED RELEASE PRODUCTS
[J].
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION,
1957, 46 (09)
:572-573
[8]
SULFAMETHYLTHIADIAZOLE - HUMAN BLOOD CONCENTRATION AND URINARY EXCRETION DATA FOLLOWING ORAL DOSES
[J].
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION,
1958, 47 (12)
:874-878
[9]
SULFAETHYLTHIADIAZOLE .5. DESIGN AND STUDY OF AN ORAL SUSTAINED RELEASE DOSAGE FORM
[J].
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION,
1959, 48 (08)
:473-478
[10]
ILLUSTRATIONS AND PHARMACEUTICAL INTERPRETATIONS OF 1ST ORDER DRUG ELIMINATION RATE FROM THE BLOODSTREAM
[J].
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION,
1956, 45 (06)
:395-400